nach oben

Erschienen in:

2015 | Sepsis | OriginalPaper | Buchkapitel

17. Sepsis und Multiorganversagen

verfasst von : Andreas Meier-Hellmann, Prof. Dr., Gerald Burgard, Dr.

Erschienen in: NeuroIntensiv

Verlag: Springer Berlin Heidelberg

Einloggen, um Zugang zu erhalten

Zusammenfassung

Sepsis, septischer Schock und sepsisinduziertes Multiorganversagen haben einen wesentlichen Anteil an der Mortalität von Patienten auf Intensivstationen. Trotz vieler Weiterentwicklungen auf dem Gebiet der Intensivmedizin hat sich die Letalität der Sepsis (35−70 %) in den letzten Jahren nicht wesentlich geändert. Die verschiedenen Aspekte der Pathophysiologie bei Sepsis sind Thema unzähliger Untersuchungen und Veröffentlichungen der letzten Jahre. Obwohl viele der so gewonnenen Erkenntnisse dazu beigetragen haben, das Krankheitsbild der Sepsis besser zu verstehen, haben nur wenige auch neue oder verbesserte Therapieansätze hervorgebracht. So sind das Zusammenspiel und die Bedeutung der verschiedenen Mediatoren des inflammatorischen Systems heute besser bekannt. Wesentliche therapeutische Optionen haben sich daraus bisher aber nicht ergeben. Ein wichtiger Bestandteil der Therapie bei Sepsis und Multiorganversagen ist daher nach wie vor eine adäquate und differenzierte Kreislauftherapie.

Abraham E, Reinhart K, Opal S, Demeyer I, Doig C, Rodriguez AL, Beale R, Svoboda P, Laterre PF, Simon S, Light B, Spapen H, Stone J, Seibert A, Peckelsen C, De Deyne C, Postier R, Pettila V, Artigas A, Percell SR, Shu V, Zwingelstein C, Tobias J, Poole L, Stolzenbach JC, Creasey AA (2003) Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: a randomized controlled trial. JAMA 290(2):238–247PubMedCrossRef

Allman KG, Stoddart AP, Kennedy MM, Young JD (1996) L-arginine augments nitric oxide production and mesenteric blood flow in ovine endotoxemia. Am J Physiol 271(4 Pt 2):H1296–301PubMed

Annane D, Sebille V, Charpentier C, Bollaert PE, Francois B, Korach JM, Capellier G, Cohen Y, Azoulay E, Troche G, Chaumet-Riffaut P, Bellissant E (2002) Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 288(7):862–871PubMedCrossRef

Annane D, Vignon P, Renault A, Bollaert PE, Charpentier C, Martin C, Troche G, Ricard JD, Nitenberg G, Papazian L, Azoulay E, Bellissant E (2007) Norepinephrine plus dobutamine versus epinephrine alone for management of septic shock: a randomised trial. Lancet 370(9588:676–684CrossRef

Annane D, Siami S, Jaber S et al (2013) Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: the CRISTAL randomized trial. JAMA 310:1809–1817PubMedCrossRef

Audebert HJ, Rott MM, Eck T, Haberl RL (2004) Systemic inflammatory response depends on initial stroke severity but is attenuated by successful thrombolysis. Stroke 35(9):2128–2133PubMedCrossRef

Battistini B, Forget MA, Laight D (1996) Potential roles for endothelins in systemic inflammatory response syndrome with a particular relationship to cytokines. Shock 5(3):167–183PubMedCrossRef

Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, Steingrub JS, Garber GE, Helterbrand JD, Ely EW, Fisher CJ (2001) Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 344(10):699–709PubMedCrossRef

Bertolini G, Iapichino G, Radrizzani D, Facchini R, Simini B, Bruzzone P, Zanforlin G, Tognoni G (2003) Early enteral immunonutrition in patients with severe sepsis: results of an interim analysis of a randomized multicentre clinical trial. Intensive Care Med 29(5):834–840PubMedCrossRef

10.

Beutler B, Milsark IW, Cerami AC (1985) Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science 229(4716):869–871PubMedCrossRef

11.

Bollaert PE, Charpentier C, Levy B, Debouverie M, Audibert G, Larcan A (1998) Reversal of late septic shock with supraphysiologic doses of hydrocortisone. Crit Care Med 26(4):645–650PubMedCrossRef

12.

Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101(6):1644–1655PubMedCrossRef

13.

Bone RC, Fisher CJ Jr., Clemmer TP, Slotman GJ, Metz CA, Balk RA (1987) A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. N Engl J Med 317(11):653–658PubMedCrossRef

14.

Briegel J, Forst H, Haller M, Schelling G, Kilger E, Kuprat G, Hemmer B, Hummel T, Lenhart A, Heyduck M, Stoll C, Peter K (1999) Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single-center study. Crit Care Med 27(4):723–732PubMedCrossRef

15.

Brown G, Frankl D, Phang T (1996) Continuous infusion of methylene blue for septic shock. Postgrad Med J 72(852):612–614PubMedPubMedCentralCrossRef

16.

Brun-Buisson C, Doyon F, Carlet J, Dellamonica P, Gouin F, Lepoutre A, Mercier JC, Offenstadt G, Regnier B (1995) Incidence, risk factors, and outcome of severe sepsis and septic shock in adults. A multicenter prospective study in intensive care units. French ICU Group for Severe Sepsis. JAMA 274(12):968–974PubMedCrossRef

17.

Brunkhorst FM, Engel C, Bloos F, Meier-Hellmann A, Ragaller M, Weiler N, Moerer O, Gruendling M, Oppert M, Grond S, Olthoff D, Jaschinski U, John S, Rossaint R, Welte T, Schaefer M, Kern P, Kuhnt E, Kiehntopf M, Hartog C, Natanson C, Loeffler M, Reinhart K (2008) Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 358(2):125–139PubMedCrossRef

18.

Caironi P, Tognoni G, Masson S et al (2014) Albumin replacement in patients with severe sepsis or septic shock. N Engl J Med 370:1412–1421PubMedCrossRef

19.

Casey LC, Balk RA, Bone RC (1993) Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann Intern Med 119(8):771–778PubMedCrossRef

20.

Centers for Disease Control: Increase in National Hospital Discharge Survey rates for septicemia--United States, 1979–1987: JAMA 1990; 263: 937–938

21.

Dahn MS, Lange P, Lobdell K, Hans B, Jacobs LA, Mitchell RA (1987) Splanchnic and total body oxygen consumption differences in septic and injured patients. Surgery 101(1):69–80PubMed

22.

Debets JM, Kampmeijer R, van der Linden MP, Buurman WA, van der Linden CJ (1989) Plasma tumor necrosis factor and mortality in critically ill septic patients. Crit Care Med 17(6):489–494PubMedCrossRef

23.

Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale R, Calandra T, Dhainaut JF, Gerlach H, Harvey M, Marini JJ, Marshall J, Ranieri M, Ramsay G, Sevransky J, Thompson BT, Townsend S, Vender JS, Zimmerman JL, Vincent JL (2008) Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 36(1):296–327PubMedCrossRef

24.

Dive A, Foret F, Jamart J, Bulpa P, Installe E (2000) Effect of dopamine on gastrointestinal motility during critical illness. Intensive Care Med 26(7):901–907PubMedCrossRef

25.

Duke GJ, Briedis JH, Weaver RA (1994) Renal support in critically ill patients: low-dose dopamine or low-dose dobutamine? Crit Care Med 22(12):1919–1925PubMedCrossRef

26.

Finfer S, Bellomo R, Boyce N, French J, Myburgh J, Norton R (2004) A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 350(22)2247–2256

27.

Finfer S, McEvoy S, Bellomo R, McArthur C, Myburgh J, Norton R (2011) Impact of albumin compared to saline on organ function and mortality of patients with severe sepsis. Intensive Care Med 37:86–96PubMedCrossRef

28.

Forceville X, Laviolle B, Annane D, Vitoux D, Bleichner G, Korach JM, Cantais E, Georges H, Soubirou JL, Combes A, Bellissant E (2007) Effects of high doses of selenium, as sodium selenite, in septic shock: a placebo-controlled, randomized, double-blind, phase II study. Crit Care 11(4):R73PubMedPubMedCentralCrossRef

29.

Galban C, Montejo JC, Mesejo A, Marco P, Celaya S, Sanchez-Segura JM, Farre M, Bryg DJ (2000) An immune-enhancing enteral diet reduces mortality rate and episodes of bacteremia in septic intensive care unit patients. Crit Care Med 28(3):643–648PubMedCrossRef

30.

Gattinoni L, Brazzi L, Pelosi P, Latini R, Tognoni G, Pesenti A, Fumagalli R (1995) A trial of goal-oriented hemodynamic therapy in critically ill patients. SvO2 Collaborative Group. N Engl J Med 333(16):1025–1032PubMedCrossRef

31.

Gutierrez G, Clark C, Brown SD, Price K, Ortiz L, Nelson C (1994) Effect of dobutamine on oxygen consumption and gastric mucosal pH in septic patients. Am J Respir Crit Care Med 150(2):324–329PubMedCrossRef

32.

Hannemann L, Korell R, Meier-Hellmann A, Reinhart K (1993) Hypertone Lösungen auf der Intensivstation. Zentralbl Chir 118(5):245–249PubMed

33.

Hayes MA, Timmins AC, Yau EH, Palazzo M, Hinds CJ, Watson D (1994) Elevation of systemic oxygen delivery in the treatment of critically ill patients. N Engl J Med 330(24):1717–1722PubMedCrossRef

34.

Hebert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagliarello G, Tweeddale M, Schweitzer I, Yetisir E (1999) A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 340(6):409–417PubMedCrossRef

35.

Heyland DK (2007) Selenium supplementation in critically ill patients: can too much of a good thing be a bad thing? Crit Care 11(4):153PubMedPubMedCentralCrossRef

36.

Heyland DK, Cook DJ, Guyatt GH (1993) Enteral nutrition in the critically ill patient: a critical review of the evidence. Intensive Care Med 19(8):435–442PubMedCrossRef

37.

Heyland DK, Cook DJ, Guyatt GH (1994) Does the formulation of enteral feeding products influence infectious morbidity and mortality rates in the critically ill patients? A critical review of the evidence. Crit Care Med 22(7):1192–1202PubMedCrossRef

38.

Heyland DK, Cook DJ, King D, Kernerman P, Brun Buisson C (1996) Maximizing oxygen delivery in critically ill patients: a methodologic appraisal of the evidence. Crit Care Med 24(3):517–524PubMedCrossRef

39.

Heyland DK, Dhaliwal R, Suchner U, Berger MM (2005) Antioxidant nutrients: a systematic review of trace elements and vitamins in the critically ill patient. Intensive Care Med 31(3):327–337PubMedCrossRef

40.

Hill GE, Frawley WH, Griffith KE, Forestner JE, Minei JP (2003) Allogeneic blood transfusion increases the risk of postoperative bacterial infection: a meta-analysis. J Trauma 54(5):908–914PubMedCrossRef

41.

Kern H, Schroder T, Kaulfuss M, Martin M, Kox WJ, Spies CD (2001) Enoximone in contrast to dobutamine improves hepatosplanchnic function in fluid-optimized septic shock patients. Crit Care Med 29(8):1519–1525PubMedCrossRef

42.

Klinzing S, Simon M, Reinhart K, Bredle DL, Meier-Hellmann A (2003) High-dose vasopressin is not superior to norepinephrine in septic shock. Crit Care Med 31(11):2646–2650PubMedCrossRef

43.

Kreimeier U, Frey L, Dentz J, Herbel T, Messmer K (1991) Hypertonic saline dextran resuscitation during the initial phase of acute endotoxemia: effect on regional blood flow. Crit Care Med 19(6):801–809PubMedCrossRef

44.

Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S, Suppes R, Feinstein D, Zanotti S, Taiberg L, Gurka D, Kumar A, Cheang M (2006) Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 34(6):1589–1596PubMedCrossRef

45.

Landry DW, Levin HR, Gallant EM, Ashton RC Jr., Seo S, D’Alessandro D, Oz MC, Oliver JA (1997) Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation 95(5):1122–1125PubMedCrossRef

46.

Levy B, Bollaert PE, Charpentier C, Nace L, Audibert G, Bauer P, Nabet P, Larcan A (1997) Comparison of norepinephrine and dobutamine to epinephrine for hemodynamics, lactate metabolism, and gastric tonometric variables in septic shock: A prospective, randomized study. Intensive Care Med 23:282–287PubMedCrossRef

47.

Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G (2003) 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 31(4):1250–1256PubMedCrossRef

48.

Lundberg JS, Perl TM, Wiblin T, Costigan MD, Dawson J, Nettleman MD, Wenzel RP (1998) Septic shock: an analysis of outcomes for patients with onset on hospital wards versus intensive care units. Crit Care Med 26(6):1020–1024PubMedCrossRef

49.

Marik PE, Mohedin M (1994) The contrasting effects of dopamine and norepinephrine on systemic and splanchnic oxygen utilization in hyperdynamic sepsis. JAMA 272(17):1354–1357PubMedCrossRef

50.

Marik PE, Sibbald WJ (1993) Effect of stored-blood transfusion on oxygen delivery in patients with sepsis [see comments]. JAMA 269(23):3024–3029PubMedCrossRef

51.

Martikainen TJ, Tenhunen JJ, Uusaro A, Ruokonen E (2003) The effects of vasopressin on systemic and splanchnic hemodynamics and metabolism in endotoxin shock. Anesth Analg 97(6):1756–1763PubMedCrossRef

52.

Meier-Hellmann A, Bredle DL, Specht M, Hannemann L, Reinhart K (1999) Dopexamine increases splanchnic blood flow but decreases gastric mucosal pH in severe septic patients treated with dobutamine. Crit Care Med 27(10):2166–2171PubMedCrossRef

53.

Meier-Hellmann A, Reinhart K, Bredle DL, Specht M, Spies CD, Hannemann L (1997) Epinephrine impairs splanchnic perfusion in septic shock. Crit Care Med 25:399–404PubMedCrossRef

54.

Moller K, Tofteng F, Qvist T, Sahl C, Sonderkaer S, Pedersen BK (2005) Cerebral output of cytokines in patients with pneumococcal meningitis. Crit Care Med 33(5):979–983PubMedCrossRef

55.

Müller-Werdan U, Prondzinsky R, Witthaut R, Stache N, Heinroth K, Kuhn C, Schmidt H, Busch I, Werdan K (1997) The heart in sepsis and MODS. Wien Klin Wochenschr 109(Suppl. 1):3–24PubMed

56.

Myburgh JA, Finfer S, Bellomo R et al (2012) Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med 367:1901–1911PubMedCrossRef

57.

Neviere R, Mathieu D, Chagnon JL, Lebleu N, Wattel F (1996) The contrasting effects of dobutamine and dopamine on gastric mucosal perfusion in septic patients. Am J Respir Crit Care Med 154(6 Pt 1):1684–1688PubMedCrossRef

58.

Ninis N, Phillips C, Bailey L, Pollock JI, Nadel S, Britto J, Maconochie I, Winrow A, Coen PG, Booy R, Levin M (2005) The role of healthcare delivery in the outcome of meningococcal disease in children: case-control study of fatal and non-fatal cases. BMJ 330(7506):1475–1481PubMedPubMedCentralCrossRef

59.

O’Brien A, Clapp L, Singer M (2002) Terlipressin for norepinephrine-resistant septic shock. Lancet 359(9313):1209–1210PubMedCrossRef

60.

Panacek EA, Marshall JC, Albertson TE, Johnson DH, Johnson S, MacArthur RD, Miller M, Barchuk WT, Fischkoff S, Kaul M, Teoh L, Van Meter L, Daum L, Lemeshow S, Hicklin G, Doig C (2004) Efficacy and safety of the monoclonal anti-tumor necrosis factor antibody F(ab’)2 fragment afelimomab in patients with severe sepsis and elevated interleukin-6 levels. Crit Care Med 32(11:2173–2182CrossRef

61.

Peng Z, Pai P, Hong-Bao L, Rong L, Han-Min W, Chen H (2010) The impacts of continuous veno-venous hemofiltration on plasma cytokines and monocyte human leukocyte antigen-DR expression in septic patients. Cytokine 50(2):186–191PubMedCrossRef

62.

Perel P, Roberts I (2012) Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database Syst Rev 6:CD000567PubMed

63.

Perner A, Haase N, Guttormsen AB et al (2012) Hydroxyethyl starch 130/0.42 versus Ringer’s acetate in severe sepsis. N Engl J Med 367:124–134PubMedCrossRef

64.

Petros A, Bennett D, Vallance P (1991) Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock. Lancet 338(8782–8783):1557–1558PubMedCrossRef

65.

Pildal J, Gotzsche PC (2004) Polyclonal immunoglobulin for treatment of bacterial sepsis: a systematic review. Clin Infect Dis 39(1):38–46PubMedCrossRef

66.

Rangel Frausto MS, Pittet D, Costigan M, Hwang T, Davis CS, Wenzel RP (1995) The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA 273(2):117–123PubMedCrossRef

67.

Ranieri VM, Thompson BT, Barie PS et al (2012) Drotrecogin alfa (activated) in adults with septic shock. N Engl J Med 366:2055–2064PubMedCrossRef

68.

Rank N, Michel C, Haertel C, Lenhart A, Welte M, Meier-Hellmann A, Spies C (2000) N-acetylcysteine increases liver blood flow and improves liver function in septic shock patients: results of a prospective, randomized, double-blind study. Crit Care Med 28(12:3799–3807CrossRef

69.

Reinelt H, Radermacher P, Fischer G, Geisser W, Wachter U, Wiedeck H, Georgieff M, Vogt J (1997) Effects of a dobutamine-induced increase in splanchnic blood flow on hepatic metabolic activity in patients with septic shock. Anesthesiology 86:818–824PubMedCrossRef

70.

Reinhart K, Brunkhorst FM, Bone HG et al (2010) Prevention, diagnosis, treatment, and follow-up care of sepsis. First revision of the S2k Guidelines of the German Sepsis Society (DSG) and the German Interdisciplinary Association for Intensive and Emergency Care Medicine (DIVI). Anaesthesist 59(4):347–370PubMedCrossRef

71.

Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, Peterson E, Tomlanovich M (2001) Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 345(19):1368–1377PubMedCrossRef

72.

Rubanyi GM, Vanhoutte PM (1986) Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor. Am J Physiol 250(5 Pt 2):H822–827PubMed

73.

Russell JA, Walley KR, Singer J, Gordon AC, Hebert PC, Cooper DJ, Holmes CL, Mehta S, Granton JT, Storms MM, Cook DJ, Presneill JJ, Ayers D (2008) Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med 358(9):877–887PubMedCrossRef

74.

Sakka SG, Bredle DL, Reinhart K, Meier-Hellmann A (1999) Comparison between intrathoracic blood volume and cardiac filling pressures in the early phase of hemodynamic instability of patients with sepsis or septic shock. J Crit Care 14(2):78–83PubMedCrossRef

75.

Sakr Y, Maia VP, Santos C, Stracke J, Zeidan M, Bayer O, Reinhart K (2014) Adjuvant selenium supplementation in the form of sodium selenite in postoperative critically ill patients with severe sepsis. Crit Care 18:R68PubMedPubMedCentralCrossRef

76.

Sakr Y, Reinhart K, Vincent JL, Sprung CL, Moreno R, Ranieri VM, De BD, Payen D (2006) Does dopamine administration in shock influence outcome? Results of the Sepsis Occurrence in Acutely Ill Patients (SOAP) Study. Crit Care Med 34(3):589–597PubMedCrossRef

77.

Sands KE, Bates DW, Lanken PN, Graman PS, Hibberd PL, Kahn KL, Parsonnet J, Panzer R, Orav EJ, Snydman DR (1997) Epidemiology of sepsis syndrome in 8 academic medical centers. Academic Medical Center Consortium Sepsis Project Working Group. JAMA 278(3):234–240PubMedCrossRef

78.

Scheeren T, Radermacher P (1997) Prostacyclin (PGI2): new aspects of an old substance in the treatment of critically ill patients. Intensive Care Med 23(2):146–158PubMedCrossRef

79.

Schneider F, Lutun P, Hasselmann M, Stoclet JC, Tempe JD (1992) Methylene blue increases systemic vascular resistance in human septic shock. Preliminary observations. Intensive Care Med 18(5):309–311PubMedCrossRef

80.

Schortgen F, Girou E, Deye N, Brochard L (2008) The risk associated with hyperoncotic colloids in patients with shock. Intensive Care Med 34:2157–2168PubMedCrossRef

81.

Shaw AD, Bagshaw SM, Goldstein SL, Scherer LA, Duan M, Schermer CR, Kellum JA (2012) Major complications, mortality, and resource utilization after open abdominal surgery: 0.9 % saline compared to Plasma-Lyte. Ann Surg 255:821–829PubMedCrossRef

82.

Shoemaker WC, Appel PL, Kram HB, Waxman K, Lee TS (1988) Prospective trial of supranormal values of survivors as therapeutic goals in high-risk surgical patients. Chest 94(6):1176–1186PubMedCrossRef

83.

Sielenkämper AW, Meyer J, Kloppenburg H, Eicker K, Van Aken H (2001) The effects of sepsis on gut mucosal blood flow in rats. Eur J Anaesthesiol 18(10):673–678PubMedCrossRef

84.

Smith MJ, Stiefel MF, Magge S, Frangos S, Bloom S, Gracias V, Le Roux (2005) Packed red blood cell transfusion increases local cerebral oxygenation. Crit Care Med 33(5):1104–1108PubMedCrossRef

85.

Spies CD, Reinhart K, Witt I, Meier-Hellmann A, Hannemann L, Bredle DL, Schaffartzik W (1994) Influence of N-acetylcysteine on indirect indicators of tissue oxygenation in septic shock patients: results from a prospective, randomized, double-blind study. Crit Care Med 22(11):1738–1746PubMedCrossRef

86.

Sprung CL, Annane D, Keh D, Moreno R, Singer M, Freivogel K, Weiss YG, Benbenishty J, Kalenka A, Forst H, Laterre PF, Reinhart K, Cuthbertson BH, Payen D, Briegel J (2008) Hydrocortisone therapy for patients with septic shock. N Engl J Med 358(2):111–124PubMedCrossRef

87.

The Veterans Administration Systemic Sepsis Cooperative Study Group: Effect of high-dose glucocorticoid therapy on mortality in patients with clinical signs of systemic sepsis. N Engl J Med 1987; 317(11): 659–665

88.

Tiruppathi C, Naqvi T, Sandoval R, Mehta D, Malik AB (2001) Synergistic effects of tumor necrosis factor-alpha and thrombin in increasing endothelial permeability. Am J Physiol Lung Cell Mol Physiol 281(4):L958–L968PubMed

89.

Tracey KJ, Fong Y, Hesse DG, Manogue KR, Lee AT, Kuo GC, Lowry SF, Cerami A (1987) Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature 330(6149):662–664PubMedCrossRef

90.

Tuchschmidt J, Fried J, Astiz M, Rackow E (1992) Elevation of cardiac output and oxygen delivery improves outcome in septic shock. Chest 102(1):216–220PubMedCrossRef

91.

Tuchschmidt J, Fried J, Swinney R, Sharma OP (1989) Early hemodynamic correlates of survival in patients with septic shock. Crit Care Med 17(8):719–723PubMedCrossRef

92.

Uusaro A, Ruokonen E, Takala J (1995) Gastric mucosal pH does not reflect changes in splanchnic blood flow after cardiac surgery. Br J Anaesth 74(2:149–154CrossRef

93.

Vamvakas EC (2004) White blood cell-containing allogeneic blood transfusion, postoperative infection and mortality: a meta-analysis of observational ’before-and-after’ studies. Vox Sang 86(2):111–119PubMedCrossRef

94.

Van den Berghe G, de Zegher F (1996) Anterior pituitary function during critical illness and dopamine treatment. Crit Care Med 24(9):1580–1590PubMedCrossRef

95.

van Haren FM, Rozendaal FW, van der Hoeven JG (2003) The effect of vasopressin on gastric perfusion in catecholamine-dependent patients in septic shock. Chest 124(6):2256–2260PubMedCrossRef

96.

Varga C, Pavo I, Lamarque D, Szepes Z, Kiss J, Karacsony G, Laszlo FA, Laszlo F (1998) Endogenous vasopressin increases acute endotoxin shock-provoked gastrointestinal mucosal injury in the rat. Eur J Pharmacol 352(2–3):257–261PubMedCrossRef

97.

Vincent JL, Gerlach H (2004) Fluid resuscitation in severe sepsis and septic shock: An evidence-based review. Crit Care Med 32(11):S451–S454PubMedCrossRef

98.

Vincent JL, Zhang H, Szabo C, Preiser JC (2000) Effects of nitric oxide in septic shock. Am J Respir Crit Care Med 161(6:1781–1785CrossRef

99.

von Spiegel T, Wietasch G, Bursch J, Hoeft A (1996) HZV-Bestimmung mittels transpulmonaler Thermodilution. Eine Alternative zum Pulmonaliskatheter? Anaesthesist 45(11:1045–1050CrossRef

100.

Warren BL, Eid A, Singer P, Pillay SS, Carl P, Novak I, Chalupa P, Atherstone A, Penzes I, Kubler A, Knaub S, Keinecke HO, Heinrichs H, Schindel F, Juers M, Bone RC, Opal SM (2001) Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial. JAMA 286(15):1869–1878PubMedCrossRef

101.

Wilmore DW, Goodwin CW, Aulick LH, Powanda MC, Mason AD Jr., Pruitt BA Jr. (1980) Effect of injury and infection on visceral metabolism and circulation. Ann Surg 192(4):491–504PubMedPubMedCentralCrossRef

102.

Wright CE, Rees DD, Moncada S (1992) Protective and pathological roles of nitric oxide in endotoxin shock. Cardiovasc Res 26(1):48–57PubMedCrossRef

103.

Zagli G, Bonizzoli M, Spina R, Cianchi G, Pasquini A, Anichini V, Matano S, Tarantini F, Di FA, Maggi E, Peris A (2010) Effects of hemoperfusion with an immobilized polymyxin-B fiber column on cytokine plasma levels in patients with abdominal sepsis. Minerva Anestesiol 76(6):405–412PubMed

104.

Zaloga GP (1999) Early enteral nutritional support improves outcome: hypothesis or fact? Crit Care Med 27(2):259–261PubMedCrossRef

105.

Zeni F, Freeman B, Natanson C (1997) Anti-inflammatory therapies to treat sepsis and septic shock: a reassessment. Crit Care Med 25(7):1095–1100PubMedCrossRef

106.

Zolldann D, Poetter C, Hilker R, Neveling M, Waitschies B, Klein W, Nolden-Koch M, Block F, Wenchel HM, Lemmen SW (2003) Periodische Surveillance nosokomialer Infektionen auf zwei neurologischen Intensivstationen. Ein wertvolles Instrument fur das intensivmedizinische Qualitatsmanagement. Anaesthesist 52(8):690–696PubMedCrossRef

Titel: Sepsis und Multiorganversagen
verfasst von: Andreas Meier-Hellmann, Prof. Dr.
Gerald Burgard, Dr.
Verlag: Springer Berlin Heidelberg
Buch: NeuroIntensiv
Print ISBN: 978-3-662-46499-1

Electronic ISBN: 978-3-662-46500-4

Copyright-Jahr: 2015
DOI: https://doi.org/10.1007/978-3-662-46500-4_17

Neu im Fachgebiet AINS

18.04.2024 | Wirbelsäulenmetastase | Nachrichten

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

hier abonnieren

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

17. Sepsis und Multiorganversagen

Zusammenfassung

Neu im Fachgebiet AINS

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

Hochrisiko-Eingriffe für postoperative Übelkeit

Diclofenac-Gel versus Ibuprofen bei akuten Rückenschmerzen

Update AINS

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Zusammenfassung

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Neu im Fachgebiet AINS

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

Hochrisiko-Eingriffe für postoperative Übelkeit

Diclofenac-Gel versus Ibuprofen bei akuten Rückenschmerzen

Update AINS